Literature DB >> 21655844

[Smoking among adolescents and young adults in Belo Horizonte, Minas Gerais State, Brazil: the influence of family setting and social group].

Mery Natali Silva Abreu1, Charles Ferreira de Souza, Waleska Teixeira Caiaffa.   

Abstract

The study aimed to estimate smoking prevalence in Belo Horizonte, Minas Gerais State, Brazil, and related risk factors among adolescents. We used data from the household survey conducted by the Brazilian National Cancer Institute (2002-2003). The following variables were analyzed: demographic data; physical activity; smoking; and alcohol consumption. The study included information on 630 adolescents (15-24 years of age) living in Belo Horizonte. Multivariate logistic regression analyses were carried out, with hierarchical entry of variables into the model and the generalized estimating equation (GEE) method. Overall smoking prevalence was 11.7%. The following factors were associated with smoking: alcohol consumption (OR = 20.6), older age (OR = 1.2), paternal smoking (OR = 4.0), sibling smoker (OR = 2.5), and best friend smoker (OR = 5.2). Smoking prevalence among adolescents was high, increasing with age and alcohol consumption.

Entities:  

Mesh:

Year:  2011        PMID: 21655844     DOI: 10.1590/s0102-311x2011000500011

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  2 in total

1.  Prevalence of self-reported smoking experimentation in adolescents with asthma or allergic rhinitis.

Authors:  Silvia de Sousa Campos Fernandes; Cláudia Ribeiro de Andrade; Alessandra Pinheiro Caminhas; Paulo Augusto Moreira Camargos; Cássio da Cunha Ibiapina
Journal:  J Bras Pneumol       Date:  2016-04       Impact factor: 2.624

2.  Epidemiological trends of allergic diseases in adolescents.

Authors:  Silvia de Souza Campos Fernandes; Cláudia Ribeiro de Andrade; Cristina Gonçalves Alvim; Paulo Augusto Moreira Camargos; Cássio da Cunha Ibiapina
Journal:  J Bras Pneumol       Date:  2017 Sep-Oct       Impact factor: 2.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.